补肾中药调控骨髓间充质干细胞成骨分化的RNA m6A修饰作用研究
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金项目(82074134)——二至丸通过Mettl3/14介导m6A动态修饰调控骨髓间充质干细胞成骨分化抗骨质疏松的表观机制


Effects of Kidney-tonifying Herbs on Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells from the Perspective of m6A Modification
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    骨髓间充质干细胞(BMSCs)是一种成体干细胞,具有成骨细胞分化能力。BMSCs成骨分化能力减弱易导致骨质疏松等多种骨相关疾病。中医学认为“肾主骨生髓”,补肾中药是治疗骨质疏松的常用药物,具有调控BMSCs成骨分化作用。腺苷N6位甲基化修饰(m6A)是真核生物RNA的转录后修饰,是BMSCs成骨分化的关键因素。探讨m6A动态修饰与BMSCs成骨分化的关系,分析补肾中药调控m6A修饰的可能作用及靶点,能够为补肾中药治疗骨质疏松提供新靶点,为中医肾藏象理论的科学阐释提供思路。

    Abstract:

    Bone marrow mesenchymal stem cells(BMSCs) are adult stem cells with osteogenic differentiation ability.The weakening osteogenic differentiation ability of BMSCs can easily lead to a variety of bone-related diseases,such as osteoporosis.Based on the theory of traditional Chinese medicine that “kidney governs the bone and generates the marrow”,kidney-tonifying herbs are commonly used in the treatment of osteoporosis,which has the effect of regulating osteogenic differentiation of BMSCs.N6-methyladenosine(m6A) is a post-transcriptional modification of eukaryotic RNA and a key factor in osteogenic differentiation of BMSCs.This study explores the relationship between m6A dynamic modification and osteogenic differentiation of BMSCs,and analyzes the possible role and targets of kidney-tonifying herbs in regulating m6A modification,which can provide new targets for kidney-tonifying herbs in the treatment of osteoporosis,and provide ideas for the scientific interpretation of the theory of visceral manifestation of kidney in traditional Chinese medicine.

    参考文献
    相似文献
    引证文献
引用本文

李沂霖,王花欣,田硕,王洁,董仁超,刘艳秋.补肾中药调控骨髓间充质干细胞成骨分化的RNA m6A修饰作用研究[J].世界中医药,2024,(02).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-05-18
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-03-20
  • 出版日期:
文章二维码